Patents/Assignees

VIVET THERAPEUTICS

1 patent in portfolio

US12385063utility2025
Codon-optimized ABCB11 Transgene for the Treatment of Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC2)
0 cites